Out-of-Pocket Healthcare 2012


April 3, 2012
50 Pages - SKU: KLI3824188
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies.  The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates.  While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Unique financial services have been created to facilitate non-insurance-paid health care services, and more are expected to be created in the near term.

This report, Out of Pocket Healthcare 2012, focuses on those costs of health care which are not paid for by government or private insurance. Once a small percentage of costs of the health care system, the percentage borne by the consumer is increasing steadily. Included in the report is:

  •     Estimates of the Current 'Out of Pocket' Healthcare Spending Market and Forecasts to 2016.
  •     Method of Payment Estimates (Cash, Credit, FSA, HSA, Healthcare Financing, Loans/LOCs)
  •     Forecasts of Spending by Type (Elective, Hospital, Emergency Room, Dental, Vision, Prescription Drugs,      Office Based Visit)
  •     Health Care Reform and Its Impact on Out of Pocket Spending
  •     Statistics For the Types of Consumers Most Likely to Pay Out of Pocket
  •     Drivers of the Out of Pocket Trend and Potential Limiters
  •     Overview of the U.S. Healthcare System, Insured and Uninsured Population.

The economic recession of December 2007 to October 2009 and weak recovery thereafter has represented a major downturn that led to broad-based cost-cutting, rising unemployment and reduced disposable income.   As part of Kalorama Information's trusted process, secondary research from government, medical and industry sources was utilized along with interviews with industry experts in the healthcare finance industry.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/



More Prescription Drugs reports by Kalorama Information

The U.S. Market for Urgent Care Centers by Kalorama Information
Urgent care centers in the United States provide an increasingly important option between a physician’s office and a hospital emergency room. They provide ...
The U.S. Market for Rx to OTC Switches, 6th Edition by Kalorama Information
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available ...
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) by Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological ...
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) by Kalorama Information
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Prescription Drugs Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!